Prior-authorization programs for controlling drug spending

被引:25
作者
Hamel, MB
Epstein, AM
机构
关键词
D O I
10.1056/NEJMp048294
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:2156 / 2158
页数:3
相关论文
共 4 条
[1]  
*HJ KAIS FAM FDN K, MED DRUG BEN HIGHL K
[2]   The effect of incentive-based formularies on prescription-drug utilization and spending [J].
Huskamp, HA ;
Deverka, PA ;
Epstein, AM ;
Epstein, RS ;
McGuigan, KA ;
Frank, RG .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (23) :2224-2232
[3]   Trends in US health care spending, 2001 [J].
Levit, K ;
Smith, C ;
Cowan, C ;
Lazenby, H ;
Sensenig, A ;
Catlin, A .
HEALTH AFFAIRS, 2003, 22 (01) :154-164
[4]   The pharmaceutical industry versus Medicaid - Limits on state initiatives to control prescription-drug costs [J].
Mello, MM ;
Studdert, DM ;
Brennan, TA .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (06) :608-613